Summary

The organoids market size is expected to grow from US$ 3.03 billion in 2023 to US$ 15.01 billion by 2031; it is projected to register a CAGR of 22.3% during 2023–2031. The organoids market growth is attributed to the increasing demand for tumor modeling & biobanking, and a surging adoption of personalized drugs. However, the dearth of skilled professionals and stringent safety regulations hinder the growth of the market. Key developments by companies are likely to offer opportunities for market growth.

The organoids market has been segmented into the 5 major regions: North America, Europe, Asia Pacific, Middle East and Africa, South and Central America. North America dominates the organoids market. US held the major market share in the North America organoids market followed by Canada and Mexico.

In Canada, renal replacement procedures increased with an average rate of 1.4% per year from 2012 to 2021, as per the data published by the Canadian Institute for Health Information in January 2023. In the same period, organ donation and transplantation increased by 23%. A total of 2,750 transplantations occurred in 2021, while the count of organ donations was 1,328. The development of kidney organoids from human-induced pluripotent stem cells represents an essential advancement in regenerative medicine. They are expected to be used for disease modeling and drug discovery and might be applicable for organ transplantation. Moreover, several funds are allocated to research organizations to encourage the development of organoids. For instance, researchers at the University of Toronto received nearly US$ 27.31 million (CA$ 21 million) in funding from Medicine by Design during 2019–2021. Also, a US$ 148.3 million (CA$ 114 million) grant was provided to Medicine by Design as the Canada First Research Excellence Fund. Therefore, offering grants is a strategic initiative to catalyze transformative findings in regenerative medicine and accelerate them toward clinical impact through the convergence of engineering, medicine, and science. Market players are also focusing on organic growth strategies to strengthen their foothold. In April 2022, BC Children's Hospital Foundation launched new stem cell research technology at BC Children's Hospital. The hospital aims to combine and automate all aspects of stem cell culturing into a single piece of equipment at its Cellular and Regenerative Medicine Centre. Thus, the growing investment in the development of organoids is expected to fuel the organoids market in Canada over the forecast period.

By Application, Organoids Market-Based Insights

Based on application, the organoids market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023–2031. Developmental biology is the study of processes involved in the growth and development of multicellular organisms; these processes are predominantly controlled by their genes. Organoids developed from stem cells or tissues in culture can be transformed into structures that resemble the in-vivo anatomy and physiology of intact organs. Human organoid cultures can be used to study human development and model diseases with the same depth of analysis that is customary for research with nonhuman model organisms. With technological advancements, 3D bioprinting have been shown to possess massive potential to aid in organ development, as the time required for building organoids through 3D printing is much less than traditional tissue culture methods. Studies enabled by patient-derived human organoids may lead to new possibilities in the fields such as tissue engineering and regenerative medicine, generating knowledge and tools for preclinical testing in drug development studies.

The growth of the organoids market for developmental biology applications is attributed to the acceptance of organoids as the primary investigative research tool in human developmental biology. Moreover, organoids grown from embryonic stem cells offer a complete understanding of embryonic process development and insights into stem cell development.

Key players identified and evaluated while performing organoids market analysis are STEMCELL Technologies; Molecular Devices, LLC.; HUB Organoids B.V. (Hubrecht Organoid Technology); DefiniGEN; Organoid Therapeutics; Thermo Fisher Scientific Inc.; Corning Inc.; Merck KGaA; InSphero; ACRO Biosystems; and Bio-Techne Corporation.

In Nov-2022, ACROBiosystems developed a series of high-quality ActiveMax cytokines to support research on organoid cell culturing. The cytokines, including EGF, Noggin, R-Spondin 1, FGF10, FGF2, and Activin A, serve as growth factors for organoid culture and have been verified to promote organoid growth.

In Jul-2023, Molecular Devices, LLC expanded its organoid line services to support next-generation drug discovery by scaling up the production of standardized, assay-ready organoids, leveraging proprietary bioreactor and bioprocess technology.

In Feb-2023, Thermo Fisher Scientific and Celltrio collaborated to bring a fully automated cell culture system to biotherapeutics customers. The collaboration will integrate the Thermo Scientific Momentum workflow scheduling software with the Celltrio RoboCell cell line automation platform to address the unmet market need for high-throughput automated cell line culturing and maintenance

Investor Presentation, World Health Organization, National Institutes of Health, Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration (FDA), US Bureau of Labor Statistics, are a few of the major secondary sources referred to while preparing the report on the organoids market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
3.3 PEST Analysis
4. Organoids Market – Key Market Dynamics
4.1 Organoids Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Demand for Tumor Modeling and Biobanking
4.2.2 Surging Adoption of Personalized Drugs
4.3 Market Restraints
4.3.1 Dearth of Skilled Professionals
4.4 Market Opportunities
4.4.1 Focus on Drug Discovery Activities
4.5 Future Trends
4.5.1 Combination of Organoids and Organ-on-a-Chip
4.6 Impact of Drivers and Restraints:
5. Organoids Market – Global Market Analysis
5.1 Organoids Market Revenue (US$ Million), 2021–2031
5.2 Organoids Market Forecast Analysis
6. Organoids Market Analysis – by Type
6.1 Intestine
6.1.1 Overview
6.1.2 Intestine: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.2 Liver
6.2.1 Overview
6.2.2 Liver: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Stomach
6.3.1 Overview
6.3.2 Stomach: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.4 Pancreas
6.4.1 Overview
6.4.2 Pancreas: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.5 Lung
6.5.1 Overview
6.5.2 Lung: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.6 Brain
6.6.1 Overview
6.6.2 Brain: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.7 Kidney
6.7.1 Overview
6.7.2 Kidney: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
6.8 Others
6.8.1 Overview
6.8.2 Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7. Organoids Market Analysis – by Application
7.1 Developmental Biology Disease
7.1.1 Overview
7.1.2 Developmental Biology Disease: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Pathology of Infectious Disease
7.2.1 Overview
7.2.2 Pathology of Infectious Disease: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Regenerative Medicine
7.3.1 Overview
7.3.2 Regenerative Medicine: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Drug Toxicity and Efficacy Testing
7.4.1 Overview
7.4.2 Drug Toxicity and Efficacy Testing: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Drug Discovery and Personalized Medicine
7.5.1 Overview
7.5.2 Drug Discovery and Personalized Medicine: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
8. Organoids Market Analysis – by Source
8.1 Pluripotent Stem Cells
8.1.1 Overview
8.1.2 Pluripotent Stem Cells: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Organ Specific Adult Stem Cell
8.2.1 Overview
8.2.2 Organ Specific Adult Stem Cell: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
9. Organoids Market Analysis – by Offerings
9.1 Instruments
9.1.1 Overview
9.1.2 Instruments: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Consumables
9.2.1 Overview
9.2.2 Consumables: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Services
9.3.1 Overview
9.3.2 Services: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
10. Organoids Market Analysis – by Method
10.1 Micropatterned Plates
10.1.1 Overview
10.1.2 Micropatterned Plates: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Ultralow Attachment Plates
10.2.1 Overview
10.2.2 Ultralow Attachment Plates: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Hanging Drop
10.3.1 Overview
10.3.2 Hanging Drop: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Microdroplet/Emulsion
10.4.1 Overview
10.4.2 Microdroplet/Emulsion: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11. Organoids Market – Geographical Analysis
11.1 Overview
11.2 North America
11.2.1 North America Organoids Market Overview
11.2.2 North America: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.2.3 North America: Organoids Market Breakdown, by Type
11.2.3.1 North America: Organoids Market – Revenue and Forecast Analysis – by Type
11.2.4 North America: Organoids Market Breakdown, by Application
11.2.4.1 North America: Organoids Market – Revenue and Forecast Analysis – by Application
11.2.5 North America: Organoids Market Breakdown, by Source
11.2.5.1 North America: Organoids Market – Revenue and Forecast Analysis – by Source
11.2.6 North America: Organoids Market Breakdown, by Offerings
11.2.6.1 North America: Organoids Market – Revenue and Forecast Analysis – by Offerings
11.2.7 North America: Organoids Market Breakdown, by Method
11.2.7.1 North America: Organoids Market – Revenue and Forecast Analysis – by Method
11.2.8 North America: Organoids Market – Revenue and Forecast Analysis – by Country
11.2.8.1 North America: Organoids Market – Revenue and Forecast Analysis – by Country
11.2.8.2 United States: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.2.8.2.1 United States: Organoids Market Breakdown, by Type
11.2.8.2.2 United States: Organoids Market Breakdown, by Application
11.2.8.2.3 United States: Organoids Market Breakdown, by Source
11.2.8.2.4 United States: Organoids Market Breakdown, by Offerings
11.2.8.2.5 United States: Organoids Market Breakdown, by Method
11.2.8.3 Canada: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.2.8.3.1 Canada: Organoids Market Breakdown, by Type
11.2.8.3.2 Canada: Organoids Market Breakdown, by Application
11.2.8.3.3 Canada: Organoids Market Breakdown, by Source
11.2.8.3.4 Canada: Organoids Market Breakdown, by Offerings
11.2.8.3.5 Canada: Organoids Market Breakdown, by Method
11.2.8.4 Mexico: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.2.8.4.1 Mexico: Organoids Market Breakdown, by Type
11.2.8.4.2 Mexico: Organoids Market Breakdown, by Application
11.2.8.4.3 Mexico: Organoids Market Breakdown, by Source
11.2.8.4.4 Mexico: Organoids Market Breakdown, by Offerings
11.2.8.4.5 Mexico: Organoids Market Breakdown, by Method
11.3 Europe
11.3.1 Europe Organoids Market Overview
11.3.2 Europe: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.3 Europe: Organoids Market Breakdown, by Type
11.3.3.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Type
11.3.4 Europe: Organoids Market Breakdown, by Application
11.3.4.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Application
11.3.5 Europe: Organoids Market Breakdown, by Source
11.3.5.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Source
11.3.6 Europe: Organoids Market Breakdown, by Offerings
11.3.6.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Offerings
11.3.7 Europe: Organoids Market Breakdown, by Method
11.3.7.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Method
11.3.8 Europe: Organoids Market – Revenue and Forecast Analysis – by Country
11.3.8.1 Europe: Organoids Market – Revenue and Forecast Analysis – by Country
11.3.8.2 Germany: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.2.1 Germany: Organoids Market Breakdown, by Type
11.3.8.2.2 Germany: Organoids Market Breakdown, by Application
11.3.8.2.3 Germany: Organoids Market Breakdown, by Source
11.3.8.2.4 Germany: Organoids Market Breakdown, by Offerings
11.3.8.2.5 Germany: Organoids Market Breakdown, by Method
11.3.8.3 France: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.3.1 France: Organoids Market Breakdown, by Type
11.3.8.3.2 France: Organoids Market Breakdown, by Application
11.3.8.3.3 France: Organoids Market Breakdown, by Source
11.3.8.3.4 France: Organoids Market Breakdown, by Offerings
11.3.8.3.5 France: Organoids Market Breakdown, by Method
11.3.8.4 United Kingdom: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.4.1 United Kingdom: Organoids Market Breakdown, by Type
11.3.8.4.2 United Kingdom: Organoids Market Breakdown, by Application
11.3.8.4.3 United Kingdom: Organoids Market Breakdown, by Source
11.3.8.4.4 United Kingdom: Organoids Market Breakdown, by Offerings
11.3.8.4.5 United Kingdom: Organoids Market Breakdown, by Method
11.3.8.5 Italy: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.5.1 Italy: Organoids Market Breakdown, by Type
11.3.8.5.2 Italy: Organoids Market Breakdown, by Application
11.3.8.5.3 Italy: Organoids Market Breakdown, by Source
11.3.8.5.4 Italy: Organoids Market Breakdown, by Offerings
11.3.8.5.5 Italy: Organoids Market Breakdown, by Method
11.3.8.6 Spain: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.6.1 Spain: Organoids Market Breakdown, by Type
11.3.8.6.2 Spain: Organoids Market Breakdown, by Application
11.3.8.6.3 Spain: Organoids Market Breakdown, by Source
11.3.8.6.4 Spain: Organoids Market Breakdown, by Offerings
11.3.8.6.5 Spain: Organoids Market Breakdown, by Method
11.3.8.7 Rest of Europe: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.3.8.7.1 Rest of Europe: Organoids Market Breakdown, by Type
11.3.8.7.2 Rest of Europe: Organoids Market Breakdown, by Application
11.3.8.7.3 Rest of Europe: Organoids Market Breakdown, by Source
11.3.8.7.4 Rest of Europe: Organoids Market Breakdown, by Offerings
11.3.8.7.5 Rest of Europe: Organoids Market Breakdown, by Method
11.4 Asia Pacific
11.4.1 Asia Pacific Organoids Market Overview
11.4.2 Asia Pacific: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.3 Asia Pacific: Organoids Market Breakdown, by Type
11.4.3.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Type
11.4.4 Asia Pacific: Organoids Market Breakdown, by Application
11.4.4.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Application
11.4.5 Asia Pacific: Organoids Market Breakdown, by Source
11.4.5.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Source
11.4.6 Asia Pacific: Organoids Market Breakdown, by Offerings
11.4.6.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Offerings
11.4.7 Asia Pacific: Organoids Market Breakdown, by Method
11.4.7.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Method
11.4.8 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Country
11.4.8.1 Asia Pacific: Organoids Market – Revenue and Forecast Analysis – by Country
11.4.8.2 Japan: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.2.1 Japan: Organoids Market Breakdown, by Type
11.4.8.2.2 Japan: Organoids Market Breakdown, by Application
11.4.8.2.3 Japan: Organoids Market Breakdown, by Source
11.4.8.2.4 Japan: Organoids Market Breakdown, by Offerings
11.4.8.2.5 Japan: Organoids Market Breakdown, by Method
11.4.8.3 China: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.3.1 China: Organoids Market Breakdown, by Type
11.4.8.3.2 China: Organoids Market Breakdown, by Application
11.4.8.3.3 China: Organoids Market Breakdown, by Source
11.4.8.3.4 China: Organoids Market Breakdown, by Offerings
11.4.8.3.5 China: Organoids Market Breakdown, by Method
11.4.8.4 India: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.4.1 India: Organoids Market Breakdown, by Type
11.4.8.4.2 India: Organoids Market Breakdown, by Application
11.4.8.4.3 India: Organoids Market Breakdown, by Source
11.4.8.4.4 India: Organoids Market Breakdown, by Offerings
11.4.8.4.5 India: Organoids Market Breakdown, by Method
11.4.8.5 South Korea: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.5.1 South Korea: Organoids Market Breakdown, by Type
11.4.8.5.2 South Korea: Organoids Market Breakdown, by Application
11.4.8.5.3 South Korea: Organoids Market Breakdown, by Source
11.4.8.5.4 South Korea: Organoids Market Breakdown, by Offerings
11.4.8.5.5 South Korea: Organoids Market Breakdown, by Method
11.4.8.6 Australia: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.6.1 Australia: Organoids Market Breakdown, by Type
11.4.8.6.2 Australia: Organoids Market Breakdown, by Application
11.4.8.6.3 Australia: Organoids Market Breakdown, by Source
11.4.8.6.4 Australia: Organoids Market Breakdown, by Offerings
11.4.8.6.5 Australia: Organoids Market Breakdown, by Method
11.4.8.7 Rest of APAC: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.4.8.7.1 Rest of APAC: Organoids Market Breakdown, by Type
11.4.8.7.2 Rest of APAC: Organoids Market Breakdown, by Application
11.4.8.7.3 Rest of APAC: Organoids Market Breakdown, by Source
11.4.8.7.4 Rest of APAC: Organoids Market Breakdown, by Offerings
11.4.8.7.5 Rest of APAC: Organoids Market Breakdown, by Method
11.5 Middle East and Africa
11.5.1 Middle East and Africa Organoids Market Overview
11.5.2 Middle East and Africa: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.5.3 Middle East and Africa: Organoids Market Breakdown, by Type
11.5.3.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Type
11.5.4 Middle East and Africa: Organoids Market Breakdown, by Application
11.5.4.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Application
11.5.5 Middle East and Africa: Organoids Market Breakdown, by Source
11.5.5.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Source
11.5.6 Middle East and Africa: Organoids Market Breakdown, by Offerings
11.5.6.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Offerings
11.5.7 Middle East and Africa: Organoids Market Breakdown, by Method
11.5.7.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Method
11.5.8 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Country
11.5.8.1 Middle East and Africa: Organoids Market – Revenue and Forecast Analysis – by Country
11.5.8.2 Saudi Arabia: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.5.8.2.1 Saudi Arabia: Organoids Market Breakdown, by Type
11.5.8.2.2 Saudi Arabia: Organoids Market Breakdown, by Application
11.5.8.2.3 Saudi Arabia: Organoids Market Breakdown, by Source
11.5.8.2.4 Saudi Arabia: Organoids Market Breakdown, by Offerings
11.5.8.2.5 Saudi Arabia: Organoids Market Breakdown, by Method
11.5.8.3 South Africa: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.5.8.3.1 South Africa: Organoids Market Breakdown, by Type
11.5.8.3.2 South Africa: Organoids Market Breakdown, by Application
11.5.8.3.3 South Africa: Organoids Market Breakdown, by Source
11.5.8.3.4 South Africa: Organoids Market Breakdown, by Offerings
11.5.8.3.5 South Africa: Organoids Market Breakdown, by Method
11.5.8.4 United Arab Emirates: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.5.8.4.1 United Arab Emirates: Organoids Market Breakdown, by Type
11.5.8.4.2 United Arab Emirates: Organoids Market Breakdown, by Application
11.5.8.4.3 United Arab Emirates: Organoids Market Breakdown, by Source
11.5.8.4.4 United Arab Emirates: Organoids Market Breakdown, by Offerings
11.5.8.4.5 United Arab Emirates: Organoids Market Breakdown, by Method
11.5.8.5 Rest of Middle East and Africa: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.5.8.5.1 Rest of Middle East and Africa: Organoids Market Breakdown, by Type
11.5.8.5.2 Rest of Middle East and Africa: Organoids Market Breakdown, by Application
11.5.8.5.3 Rest of Middle East and Africa: Organoids Market Breakdown, by Source
11.5.8.5.4 Rest of Middle East and Africa: Organoids Market Breakdown, by Offerings
11.5.8.5.5 Rest of Middle East and Africa: Organoids Market Breakdown, by Method
11.6 South and Central America
11.6.1 South and Central America Organoids Market Overview
11.6.2 South and Central America: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.6.3 South and Central America: Organoids Market Breakdown, by Type
11.6.3.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Type
11.6.4 South and Central America: Organoids Market Breakdown, by Application
11.6.4.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Application
11.6.5 South and Central America: Organoids Market Breakdown, by Source
11.6.5.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Source
11.6.6 South and Central America: Organoids Market Breakdown, by Offerings
11.6.6.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Offerings
11.6.7 South and Central America: Organoids Market Breakdown, by Method
11.6.7.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Method
11.6.8 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Country
11.6.8.1 South and Central America: Organoids Market – Revenue and Forecast Analysis – by Country
11.6.8.2 Brazil: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.6.8.2.1 Brazil: Organoids Market Breakdown, by Type
11.6.8.2.2 Brazil: Organoids Market Breakdown, by Application
11.6.8.2.3 Brazil: Organoids Market Breakdown, by Source
11.6.8.2.4 Brazil: Organoids Market Breakdown, by Offerings
11.6.8.2.5 Brazil: Organoids Market Breakdown, by Method
11.6.8.3 Argentina: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.6.8.3.1 Argentina: Organoids Market Breakdown, by Type
11.6.8.3.2 Argentina: Organoids Market Breakdown, by Application
11.6.8.3.3 Argentina: Organoids Market Breakdown, by Source
11.6.8.3.4 Argentina: Organoids Market Breakdown, by Offerings
11.6.8.3.5 Argentina: Organoids Market Breakdown, by Method
11.6.8.4 Rest of South and Central America: Organoids Market – Revenue and Forecast to 2031 (US$ Million)
11.6.8.4.1 Rest of South and Central America: Organoids Market Breakdown, by Type
11.6.8.4.2 Rest of South and Central America: Organoids Market Breakdown, by Application
11.6.8.4.3 Rest of South and Central America: Organoids Market Breakdown, by Source
11.6.8.4.4 Rest of South and Central America: Organoids Market Breakdown, by Offerings
11.6.8.4.5 Rest of South and Central America: Organoids Market Breakdown, by Method
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in Organoids Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 STEMCELL Technologies Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Molecular Devices, LLC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Hubrecht Organoid Technology
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Definigen
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Organoid Therapeutics
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Thermo Fisher Scientific Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Corning Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Merck KGaA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 InSphero
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 ACRO Biosystems.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Bio-Techne Corp
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 SUN bioscience SA
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 ORGANOID SCIENCES Co., Ltd.
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 Crown Bioscience Inc
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Sartorius AG
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 3D Biotek LLC
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 Prellis Biologics Inc.
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 3Dnamics Inc.
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
13.19 Cellesce Ltd
13.19.1 Key Facts
13.19.2 Business Description
13.19.3 Products and Services
13.19.4 Financial Overview
13.19.5 SWOT Analysis
13.19.6 Key Developments
14. Appendix
14.1 About The Insight Partners